Submit your Manuscript
  • info@jjgastro.com
  • ISSN 3065-5498
Submit your Manuscript

Volume 4, Issue 8

Dysphagia lusoria: A rare vascular anomaly

www.doi.org/10.52768/jjgastro/1213

A 39-year-old female with a past medical history of chronic bronchitis presented for evaluation of progressive dysphagia. She reported a long-standing history of difficulty swallowing, often experiencing transient substernal obstruction of solid food and occasionally liquids. Her symptoms subsequently progressed until she was tolerating only minimal oral intake accompanied by unintentional weight loss, prompting her to seek care.

Effect of tryptophan restriction in the therapy of irritable bowel syndrome: A systematic review

www.doi.org/10.52768/jjgastro/1214

The metabolic pathways of Tryptophan (TRP) have been implicated in the pathophysiology of Irritable Bowel Syndrome (IBS), positing that the strategic modulation of TRP consumption may exert regulatory effects on serotonin levels, consequently altering the clinical manifestation of IBS.

Pneumatosis intestinalis

www.doi.org/10.52768/jjgastro/1215

Pneumatosis intestinalis is a rare condition characterized by the presence of gas bubbles within the mucosa of the gastrointestinal tract. This article presents the case of a woman who showed significant improvement following conservative treatment.

Gastric mucormycosis post COVID-19

Mucormycosis is a serious disease caused by fungi of the Mucorales order Mucorales. The main risk factors of mucormycosis include diabetes mellitus, phagocyte deficiency, corticosteroid use and organ or stem cell transplantation. More recently, COVID-19 has become a risk factor described in some case reports, increasing the importance of diagnostic suspicion in patients with COVID-19 and clinical signs compatible with mucormycosis.